Tumor necrosis factor (TNF)-alpha inhibitors are used to treat a variety of autoimmune conditions including psoriasis, psoriatic arthritis, rheumatoid arthritis (RA), spondyloarthritis, and inflammatory bowel disease (IBD). Interestingly, they have also been observed to cause paradoxical psoriasis with an incidence between 0.6%-5.3%, most commonly occurring in patients with underlying Crohns disease and rheumatoid arthritis (RA). Infliximab is the most common TNF inhibitor associated with this condition (52.6%-62.6% of cases) followed by etanercept (12%-29%). TNF inhibitor-induced psoriasis most often presents as plaque or palmoplantar psoriasis, but other subtypes have also been documented.
Psoriasis is traditionally divided into two types. Patients with type I psoriasis have a family history, develop symptoms before the age of 40 and are often positive for HLA-Cw6. Type II psoriasis is not related to HLA-Cw6, lacks a family history, and typically manifests after age 40. Psoriatic lesions are well-defined, erythematous plaques with silvery scales most commonly appearing on extensor surfaces and the scalp. Variants include nail psoriasis, pustular psoriasis, inverse psoriasis, and guttate psoriasis.
Although psoriasis is typically a clinical diagnosis, histologic examination may be used to differentiate from other dermatoses if necessary. The lesions of TNF inhibitor-induced psoriasis characteristically display patterns similar to primary psoriasis, including parakeratosis, microabscesses, and rete ridges. Eosinophilic hypersensitivity reactions and features overlapping with eczematous hypersensitivity (psoriasiform dermatitis) may also be present.
The pathogenesis of this condition is not well understood, but theories include a variety of immune processes including interferon overproduction, interleukin and T-cell activation, and the presence of an infectious nidus. Classical psoriasis is related to type 1 interferon release, so theoretically, immunosuppression caused by TNF inhibitor treatment may permit uncontrolled production of interferons, resulting in psoriatic lesions. Another theory is that interleukin (IL)-23, a pro-inflammatory cytokine, promotes activation of T-helper 17 (Th17) cells. Th17 cells are part of the pathogenesis of primary psoriasis and other inflammatory conditions, such as RA and inflammatory bowel disease. Of note, individuals with gastrointestinal inflammatory diseases are already known to be at a greater risk for developing psoriasis. Immunosuppression caused by a TNF inhibitor may leave patients more susceptible to other infections, which may induce psoriatic plaques.
There are multiple approaches to treatment depending on the severity of the disease. If the psoriatic eruption is mild, the medication may be continued. This treat-through method is often considered when stopping the current immunotherapy would cause the patient significant issues. Moderate to severe cases of TNF inhibitor-induced psoriasis may warrant switching TNF inhibitor therapy or completely changing the drug class used in the treatment of the underlying autoimmune condition. Additional treatments include topical and oral steroids, UV therapy, methotrexate, cyclosporine, and acitretin.
This case and the photo were submitted by Lucas Shapiro, BS, of Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale, Florida, and Leon S. Maratchi, MD, Gastro Health, Hollywood, Florida. The column was edited by Donna Bilu Martin, MD.
Dr. Bilu Martin is a board-certified dermatologist in private practice at Premier Dermatology, MD, in Aventura, Florida. More diagnostic cases are available at mdedge.com/dermatology. To submit a case for possible publication, send an email to dermnews@mdedge.com.
1. Li SJ et al. J Psoriasis Psoriatic Arthritis. 2019 Apr;4(2):70-80. doi: 10.1177/2475530318810851.
2. Lu J and Lu Y. J Transl Autoimmun. 2023 Sep 6:7:100211. doi: 10.1016/j.jtauto.2023.100211.
3. Nair PA and Badri T. Psoriasis. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK448194/
Excerpt from:
- American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables - Newswise - April 15th, 2024 [April 15th, 2024]
- Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Atopic Dermatitis (Eczema): 5 Top Self-Care Tips - Everyday Health - April 15th, 2024 [April 15th, 2024]
- Derm In The News: April 7-13 - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Generative models improve fairness of medical classifiers under distribution shifts - Nature.com - April 15th, 2024 [April 15th, 2024]
- 9 Best Baby Eczema Creams of 2024 to Soothe Delicate Skin, According to Dermatologists - Allure - April 15th, 2024 [April 15th, 2024]
- QUIZ: Test Your Knowledge of Rosacea Etiology, Types, and Triggers - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Empowering Patients: Effective Dermatologic Treatment Selection for Hand and Feet AD - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- How To Treat Strawberry Legs, According To Dermatologists - Women's Health - April 15th, 2024 [April 15th, 2024]
- Rosacea Awareness Month: Resources to Share With Your Patients - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Derm In The News: March 31-April 6 - Dermatology Times - April 7th, 2024 [April 7th, 2024]
- Dr. Hillary Johnson-Jahangir of Forefront Dermatology Designated as a Candela Center of Excellence - PR Newswire - April 7th, 2024 [April 7th, 2024]
- How to Boost Your Immune System While Living With Psoriasis - Everyday Health - April 7th, 2024 [April 7th, 2024]
- Im a Harvard-trained dermatologist Ive followed 3 anti-aging rules for years, Im still a fan of a drug... - The US Sun - April 7th, 2024 [April 7th, 2024]
- Cosmetic Procedures for Psoriasis: Are They Safe? - Everyday Health - April 7th, 2024 [April 7th, 2024]
- FDA Approves Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum - Dermatology Times - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - The Mountaineer - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - Islander News.com - January 8th, 2024 [January 8th, 2024]
- How To Get Rid Of Dark Spots On Your Face, Per Dermatologists - Women's Health - January 8th, 2024 [January 8th, 2024]
- POLL: What Are Your 2024 Dermatology Resolutions? - Dermatology Times - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - NBC Right Now - January 8th, 2024 [January 8th, 2024]
- Common perianal diseases and dermatology oddities - DVM 360 - January 8th, 2024 [January 8th, 2024]
- How To Keep Skin Hydrated And Protected In The Cold According To Dermatologists - Essence - January 8th, 2024 [January 8th, 2024]
- Retinol and Retinoids: 9 Things You Should Know Before Using - Vogue - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - pdclarion.com - January 8th, 2024 [January 8th, 2024]
- 8 Wintertime Skin Conditions to Look Out For - Health.com - January 8th, 2024 [January 8th, 2024]
- 9 Tips for Common Winter Skin Conditions, According to a Celeb Dermatologist - PEOPLE - January 8th, 2024 [January 8th, 2024]
- FDA Approval of ZELSUVMI Berdazimer Gel: A Revolutionary Achievement | Health News - Medriva - January 8th, 2024 [January 8th, 2024]
- Revolutionary Research Towards Acne Vaccine and Gene Editing Treatments - Medriva - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - Corydon Times - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - Hometown Register - January 8th, 2024 [January 8th, 2024]
- Rice Water for Hair Growth: Does It Really Work? - Health.com - January 8th, 2024 [January 8th, 2024]
- Dermatology Times 2023 In Review: NP and PA News - Dermatology Times - December 31st, 2023 [December 31st, 2023]
- Colorado dermatology company warning about cybersecurity threat where hacker gained access to health information - Summit Daily - December 31st, 2023 [December 31st, 2023]
- Reviewing the Top Dermatology Headlines of 2023 - Dermatology Times - December 31st, 2023 [December 31st, 2023]
- Dermatology Times 2023 In Review: Acne - Dermatology Times - December 31st, 2023 [December 31st, 2023]
- Skin to Skin: Getting to know UMs new dermatology club - The Miami Hurricane - December 22nd, 2023 [December 22nd, 2023]
- Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- Schweiger Dermatology Group Acquires New Jersey Practices of NavaDerm Partners in Millburn and Englewood Cliffs - PR Newswire - December 22nd, 2023 [December 22nd, 2023]
- Spike in dermatology visits for skin problems seen during summer of wildfires - Medical Xpress - December 22nd, 2023 [December 22nd, 2023]
- More Images of Patients With Psoriasis Are Needed in Published Studies - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- Case Based Roundtables Part 2: Valorizing Topical Treatment Options for Patients With Vitiligo - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- Practical Approaches to Atopic Dermatitis: Real-World Case Analyses - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- Schweiger Dermatology Group Expands into South Florida with Locations in West Palm Beach and Miami Beach - Tullahoma News and Guardian - December 22nd, 2023 [December 22nd, 2023]
- Receding Hairline: Symptoms, Causes, Treatments - Men's Health - December 22nd, 2023 [December 22nd, 2023]
- Podcast CE: Ophytrium in Dermatology: When, where and whys of using Douxo S3 topical therapies - DVM 360 - December 22nd, 2023 [December 22nd, 2023]
- POLL: Which Skin Cancer Drug Recently Received a Complete Response Letter From the FDA? - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- How to Treat Textured Skin, According to Dermatologists - Prevention Magazine - December 22nd, 2023 [December 22nd, 2023]
- Dermatology decoded with Dr. Davin Lim - manilastandard.net - December 22nd, 2023 [December 22nd, 2023]
- Arcutis' Zoryve bags 2nd FDA nod, this time as a foam to treat 'the great neglected disease in dermatology' - FiercePharma - December 22nd, 2023 [December 22nd, 2023]
- Moderna and Merck's V940 Plus Pembrolizumab Demonstrates Improvement in RFS and DMFS in Stage III/IV ... - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- From customised vitamin infusions to tech-driven dermatology: Skincare trends that dominated 2023 - The Indian Express - December 22nd, 2023 [December 22nd, 2023]
- Aptar Digital Health and Legit.Health Partner to Improve Patient Experience in Immuno-Dermatology - Healthcare Packaging - December 22nd, 2023 [December 22nd, 2023]
- Navigating Location Specific Treatment Selection and Topical Therapy Limitations - Dermatology Times - December 22nd, 2023 [December 22nd, 2023]
- POLL: What Percent of the Global Population is Estimated to Have ... - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- Purple Heart Project Seeks to Provide Veterans With Access to ... - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- Dermatology expert stresses importance of cytology and cultures - DVM 360 - November 18th, 2023 [November 18th, 2023]
- Shawn Kwatra, MD, Shares Highlights From the 12th World ... - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- The Weekly Roundup: November 12-17 - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- Almirall, Absci Partner to Develop AI-Designed Therapies for ... - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- The Skin of Color Society Kicks Off a Season of Giving with its My ... - PR Newswire - November 18th, 2023 [November 18th, 2023]
- Clascoterone Cream in Patients With Acne: New Long-Term Data - Medpage Today - November 18th, 2023 [November 18th, 2023]
- Discovery of hemoglobin in the epidermis sheds new light on our ... - EurekAlert - November 18th, 2023 [November 18th, 2023]
- Global Assessment of Quality of Care for Patients With Malignant ... - Dermatology Advisor - November 18th, 2023 [November 18th, 2023]
- Effective Therapies for Atopic Dermatitis: Expert Recommendations ... - HealthDay - November 18th, 2023 [November 18th, 2023]
- Nonablative Lasers Offer a Gentle Approach to Healthy Skin - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- Aging, Acne, and the Armamentarium: Hot Topics From the Science ... - Dermatology Times - November 18th, 2023 [November 18th, 2023]
- Prior Treatment Options and Outcomes for SD - MD Magazine - November 18th, 2023 [November 18th, 2023]
- Consequences of Lying on the Witness Stand: Are There Any for Dermatology Expert Witnesses? - Dermatology Times - October 27th, 2023 [October 27th, 2023]
- The Cutaneous Manifestations of Drug Reactions Can Mimic Traumatic Injuries: Case Reports and the Potential Role ... - Cureus - October 27th, 2023 [October 27th, 2023]
- Robyn Siperstein, MD, FAAD: Initiating a Patient-First Dialogue in ... - Dermatology Times - October 27th, 2023 [October 27th, 2023]
- Tralokinumab May Improve 52-Week Outcomes in Patients With Moderate to Severe Atopic Dermatitis - Dermatology Advisor - October 27th, 2023 [October 27th, 2023]
- How to Safely and Effectively Exfoliate Your Skin, According to Dermatologists - Allure - October 27th, 2023 [October 27th, 2023]
- Enhancing the Patient Experience Through Addressing Pain Points ... - Dermatology Times - October 27th, 2023 [October 27th, 2023]
- Global Dermatology Collaboration and Licensing Deals and Agreements Analysis Report 2023 with Directory of Dermatology Deal Records Signed Since 2016... - October 27th, 2023 [October 27th, 2023]
- UNION therapeutics to present at 7th Annual Dermatology Drug ... - PR Newswire - October 27th, 2023 [October 27th, 2023]
- Tareen Dermatology Expands to Hudson, Wisconsin, Adding Sixth Location within the Hudson Medical Center - Yahoo Finance - October 27th, 2023 [October 27th, 2023]
- 4 Tips and Considerations for Selecting a Systemic Treatment for ... - Dermatology Times - October 27th, 2023 [October 27th, 2023]
- Yales Richard Edelson on what got him started in research for ... - The Cancer Letter - October 27th, 2023 [October 27th, 2023]